Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis

V. S. Santos, D. Goletti, K. Kontogianni, E. R. Adams, B. Molina-Moya, J. Dominguez, V. Crudu, P. R.S. Martins-Filho, M. Ruhwald, L. Lawson, J. S. Bimba, A. L. Garcia-Basteiro, L. Petrone, B. S. Kabeer, K. Reither, L. E. Cuevas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: We examined the data reported in studies for diagnostic purposes and to discuss whether their intended use could be extended to triage, as rule-in or rule-out tests to select individuals who should undergo further confirmatory tests. Methods: We searched Scopus, PubMed and Web of Science with the terms ‘acute phase proteins,’ ‘IP-10,’ ‘tuberculosis,’ ‘screening’ and ‘diagnosis,’ extracted the sensitivity and specificity of the biomarkers and explored methodologic differences to explain performance variations. Summary estimates were calculated using random-effects models for overall pooled accuracy. The hierarchical summary receiver operating characteristic model was used for meta-analysis. Results: We identified 14, four and one studies for C-reactive protein (CRP), interferon γ–induced protein 10 (IP-10) and alpha-1-acid glycoprotein (AGP). The pooled CRP sensitivity/specificity (95% confidence interval) was 89% (80–96) and 57% (36–65). Sensitivity/specificity were higher in high-tuberculosis-burden countries (90%/64%), HIV-infected individuals (91%/61%) and community-based studies (90%/62%). IP-10 sensitivity/specificity in TB vs. non-TB studies was 85%/63% and in TB and HIV coinfected vs. other lung conditions 94%/21%. However, IP-10 studies included diverse populations and a high risk of bias, resulting in very low-quality evidence. AGP had 86%/93% sensitivity/specificity. Conclusions: Few studies have evaluated CRP, IP-10 and AGP for the triage of symptomatic patients. Their high sensitivity and moderate specificity warrant further prospective studies exploring whether their combined use could optimize performance.

Original languageEnglish
JournalClinical Microbiology and Infection
DOIs
Publication statusE-pub ahead of print - Aug 1 2018

Fingerprint

Acute-Phase Proteins
Triage
Meta-Analysis
Tuberculosis
Sensitivity and Specificity
C-Reactive Protein
Proteins
Glycoproteins
HIV
Orosomucoid
Acids
PubMed
ROC Curve
Interferons
Biomarkers
Prospective Studies
Confidence Intervals
Lung
Population

Keywords

  • Acute phase proteins
  • IP-10
  • screening
  • systematic review
  • tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis : systematic review and meta-analysis. / Santos, V. S.; Goletti, D.; Kontogianni, K.; Adams, E. R.; Molina-Moya, B.; Dominguez, J.; Crudu, V.; Martins-Filho, P. R.S.; Ruhwald, M.; Lawson, L.; Bimba, J. S.; Garcia-Basteiro, A. L.; Petrone, L.; Kabeer, B. S.; Reither, K.; Cuevas, L. E.

In: Clinical Microbiology and Infection, 01.08.2018.

Research output: Contribution to journalArticle

Santos, VS, Goletti, D, Kontogianni, K, Adams, ER, Molina-Moya, B, Dominguez, J, Crudu, V, Martins-Filho, PRS, Ruhwald, M, Lawson, L, Bimba, JS, Garcia-Basteiro, AL, Petrone, L, Kabeer, BS, Reither, K & Cuevas, LE 2018, 'Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis', Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2018.07.017
Santos, V. S. ; Goletti, D. ; Kontogianni, K. ; Adams, E. R. ; Molina-Moya, B. ; Dominguez, J. ; Crudu, V. ; Martins-Filho, P. R.S. ; Ruhwald, M. ; Lawson, L. ; Bimba, J. S. ; Garcia-Basteiro, A. L. ; Petrone, L. ; Kabeer, B. S. ; Reither, K. ; Cuevas, L. E. / Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis : systematic review and meta-analysis. In: Clinical Microbiology and Infection. 2018.
@article{82c7286081834777b4b91d1f6463b532,
title = "Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis",
abstract = "Objectives: We examined the data reported in studies for diagnostic purposes and to discuss whether their intended use could be extended to triage, as rule-in or rule-out tests to select individuals who should undergo further confirmatory tests. Methods: We searched Scopus, PubMed and Web of Science with the terms ‘acute phase proteins,’ ‘IP-10,’ ‘tuberculosis,’ ‘screening’ and ‘diagnosis,’ extracted the sensitivity and specificity of the biomarkers and explored methodologic differences to explain performance variations. Summary estimates were calculated using random-effects models for overall pooled accuracy. The hierarchical summary receiver operating characteristic model was used for meta-analysis. Results: We identified 14, four and one studies for C-reactive protein (CRP), interferon γ–induced protein 10 (IP-10) and alpha-1-acid glycoprotein (AGP). The pooled CRP sensitivity/specificity (95{\%} confidence interval) was 89{\%} (80–96) and 57{\%} (36–65). Sensitivity/specificity were higher in high-tuberculosis-burden countries (90{\%}/64{\%}), HIV-infected individuals (91{\%}/61{\%}) and community-based studies (90{\%}/62{\%}). IP-10 sensitivity/specificity in TB vs. non-TB studies was 85{\%}/63{\%} and in TB and HIV coinfected vs. other lung conditions 94{\%}/21{\%}. However, IP-10 studies included diverse populations and a high risk of bias, resulting in very low-quality evidence. AGP had 86{\%}/93{\%} sensitivity/specificity. Conclusions: Few studies have evaluated CRP, IP-10 and AGP for the triage of symptomatic patients. Their high sensitivity and moderate specificity warrant further prospective studies exploring whether their combined use could optimize performance.",
keywords = "Acute phase proteins, IP-10, screening, systematic review, tuberculosis",
author = "Santos, {V. S.} and D. Goletti and K. Kontogianni and Adams, {E. R.} and B. Molina-Moya and J. Dominguez and V. Crudu and Martins-Filho, {P. R.S.} and M. Ruhwald and L. Lawson and Bimba, {J. S.} and Garcia-Basteiro, {A. L.} and L. Petrone and Kabeer, {B. S.} and K. Reither and Cuevas, {L. E.}",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.cmi.2018.07.017",
language = "English",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis

T2 - systematic review and meta-analysis

AU - Santos, V. S.

AU - Goletti, D.

AU - Kontogianni, K.

AU - Adams, E. R.

AU - Molina-Moya, B.

AU - Dominguez, J.

AU - Crudu, V.

AU - Martins-Filho, P. R.S.

AU - Ruhwald, M.

AU - Lawson, L.

AU - Bimba, J. S.

AU - Garcia-Basteiro, A. L.

AU - Petrone, L.

AU - Kabeer, B. S.

AU - Reither, K.

AU - Cuevas, L. E.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Objectives: We examined the data reported in studies for diagnostic purposes and to discuss whether their intended use could be extended to triage, as rule-in or rule-out tests to select individuals who should undergo further confirmatory tests. Methods: We searched Scopus, PubMed and Web of Science with the terms ‘acute phase proteins,’ ‘IP-10,’ ‘tuberculosis,’ ‘screening’ and ‘diagnosis,’ extracted the sensitivity and specificity of the biomarkers and explored methodologic differences to explain performance variations. Summary estimates were calculated using random-effects models for overall pooled accuracy. The hierarchical summary receiver operating characteristic model was used for meta-analysis. Results: We identified 14, four and one studies for C-reactive protein (CRP), interferon γ–induced protein 10 (IP-10) and alpha-1-acid glycoprotein (AGP). The pooled CRP sensitivity/specificity (95% confidence interval) was 89% (80–96) and 57% (36–65). Sensitivity/specificity were higher in high-tuberculosis-burden countries (90%/64%), HIV-infected individuals (91%/61%) and community-based studies (90%/62%). IP-10 sensitivity/specificity in TB vs. non-TB studies was 85%/63% and in TB and HIV coinfected vs. other lung conditions 94%/21%. However, IP-10 studies included diverse populations and a high risk of bias, resulting in very low-quality evidence. AGP had 86%/93% sensitivity/specificity. Conclusions: Few studies have evaluated CRP, IP-10 and AGP for the triage of symptomatic patients. Their high sensitivity and moderate specificity warrant further prospective studies exploring whether their combined use could optimize performance.

AB - Objectives: We examined the data reported in studies for diagnostic purposes and to discuss whether their intended use could be extended to triage, as rule-in or rule-out tests to select individuals who should undergo further confirmatory tests. Methods: We searched Scopus, PubMed and Web of Science with the terms ‘acute phase proteins,’ ‘IP-10,’ ‘tuberculosis,’ ‘screening’ and ‘diagnosis,’ extracted the sensitivity and specificity of the biomarkers and explored methodologic differences to explain performance variations. Summary estimates were calculated using random-effects models for overall pooled accuracy. The hierarchical summary receiver operating characteristic model was used for meta-analysis. Results: We identified 14, four and one studies for C-reactive protein (CRP), interferon γ–induced protein 10 (IP-10) and alpha-1-acid glycoprotein (AGP). The pooled CRP sensitivity/specificity (95% confidence interval) was 89% (80–96) and 57% (36–65). Sensitivity/specificity were higher in high-tuberculosis-burden countries (90%/64%), HIV-infected individuals (91%/61%) and community-based studies (90%/62%). IP-10 sensitivity/specificity in TB vs. non-TB studies was 85%/63% and in TB and HIV coinfected vs. other lung conditions 94%/21%. However, IP-10 studies included diverse populations and a high risk of bias, resulting in very low-quality evidence. AGP had 86%/93% sensitivity/specificity. Conclusions: Few studies have evaluated CRP, IP-10 and AGP for the triage of symptomatic patients. Their high sensitivity and moderate specificity warrant further prospective studies exploring whether their combined use could optimize performance.

KW - Acute phase proteins

KW - IP-10

KW - screening

KW - systematic review

KW - tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85052735502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052735502&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2018.07.017

DO - 10.1016/j.cmi.2018.07.017

M3 - Article

AN - SCOPUS:85052735502

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

ER -